JP2022553540A5 - - Google Patents
Info
- Publication number
- JP2022553540A5 JP2022553540A5 JP2022523913A JP2022523913A JP2022553540A5 JP 2022553540 A5 JP2022553540 A5 JP 2022553540A5 JP 2022523913 A JP2022523913 A JP 2022523913A JP 2022523913 A JP2022523913 A JP 2022523913A JP 2022553540 A5 JP2022553540 A5 JP 2022553540A5
- Authority
- JP
- Japan
- Prior art keywords
- treg
- chain
- tcr
- seq
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (21)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1915344.4 | 2019-10-23 | ||
| GB1915357.6 | 2019-10-23 | ||
| GB1915348.5 | 2019-10-23 | ||
| GB201915357A GB201915357D0 (en) | 2019-10-23 | 2019-10-23 | Engineered regulatory t cell |
| GB1915366.7 | 2019-10-23 | ||
| GB201915360A GB201915360D0 (en) | 2019-10-23 | 2019-10-23 | Engineered regulatory t cell |
| GB201915354A GB201915354D0 (en) | 2019-10-23 | 2019-10-23 | Engineered regulatory t cell |
| GB1915362.6 | 2019-10-23 | ||
| GB201915341A GB201915341D0 (en) | 2019-10-23 | 2019-10-23 | Engineered regulatory T cell |
| GB1915360.0 | 2019-10-23 | ||
| GB201915347A GB201915347D0 (en) | 2019-10-23 | 2019-10-23 | Engineered regulatory t cell |
| GB1915341.0 | 2019-10-23 | ||
| GB1915354.3 | 2019-10-23 | ||
| GB1915351.9 | 2019-10-23 | ||
| GB201915362A GB201915362D0 (en) | 2019-10-23 | 2019-10-23 | Engineered regulatory t cell |
| GB201915366A GB201915366D0 (en) | 2019-10-23 | 2019-10-23 | Engineered regulatory t cell |
| GB201915351A GB201915351D0 (en) | 2019-10-23 | 2019-10-23 | Engineered regulatory t cell |
| GB201915348A GB201915348D0 (en) | 2019-10-23 | 2019-10-23 | Engineered regulatory t cell |
| GB1915347.7 | 2019-10-23 | ||
| GB201915344A GB201915344D0 (en) | 2019-10-23 | 2019-10-23 | Engineered regulatory T cell |
| PCT/GB2020/052659 WO2021079122A1 (en) | 2019-10-23 | 2020-10-22 | Engineered regulatory t cell |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022553540A JP2022553540A (ja) | 2022-12-23 |
| JP2022553540A5 true JP2022553540A5 (enExample) | 2023-10-19 |
Family
ID=73040143
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022523913A Pending JP2022553540A (ja) | 2019-10-23 | 2020-10-22 | 操作された制御性ｔ細胞 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US12643932B2 (enExample) |
| EP (1) | EP4048294A1 (enExample) |
| JP (1) | JP2022553540A (enExample) |
| CN (1) | CN114641564B (enExample) |
| AU (1) | AU2020370033A1 (enExample) |
| CA (1) | CA3154606A1 (enExample) |
| WO (1) | WO2021079122A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201915359D0 (en) | 2019-10-23 | 2019-12-04 | Ucl Business Ltd | Engineered regulatory t cell |
| WO2023050063A1 (zh) * | 2021-09-28 | 2023-04-06 | 溧阳瑅赛生物医药有限公司 | 一种识别hla-a*02:01/e629-38的tcr及其应用 |
| CN120091826A (zh) * | 2022-08-12 | 2025-06-03 | 阿巴塔治疗股份有限公司 | 多发性硬化症的细胞疗法 |
| EP4573114A4 (en) * | 2022-08-19 | 2026-07-29 | Memorial Sloan Kettering Cancer Center | T-LYMPHOCYTE RECEPTORS TARGETTING RAS MUTATIONS AND ASSOCIATED USES |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2825261B1 (fr) | 2001-06-01 | 2003-09-12 | Maco Pharma Sa | Ligne de prelevement du sang placentaire comprenant une poche de rincage |
| US7147626B2 (en) | 2004-09-23 | 2006-12-12 | Celgene Corporation | Cord blood and placenta collection kit |
| EP2050814A1 (en) | 2007-10-17 | 2009-04-22 | Txcell | Compositions for treating multiple sclerosis |
| GB0917094D0 (en) * | 2009-09-29 | 2009-11-11 | Ucl Biomedica Plc | T-cell receptor |
| RU2523058C2 (ru) | 2012-06-29 | 2014-07-20 | Общество с ограниченной ответственностью "Регенекс" | Способ терапии ремиттирующего рассеянного склероза |
| US9693977B2 (en) | 2013-03-15 | 2017-07-04 | President And Fellows Of Harvard College | Method of increasing the quantity of colonic T regulatory cells via G-coupled protein receptor 43 |
| WO2014183056A1 (en) * | 2013-05-10 | 2014-11-13 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | Design and use of specific regulatory t-cells to induce immune tolerance |
| JP7013240B2 (ja) | 2015-02-16 | 2022-01-31 | ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア | Ｈｅｒ２／Ｎｅｕ （ＥＲＢＢ２）受容体タンパク質に由来する３６９～３７７位エピトープに特異的な完全ヒトＴ細胞受容体 |
| GB201507368D0 (en) | 2015-04-30 | 2015-06-17 | Ucl Business Plc | Cell |
| US20190358258A1 (en) | 2015-10-09 | 2019-11-28 | Robert J. Deans | Methods for enhancing proliferation of t regulatory cells |
| US12227756B2 (en) | 2018-04-18 | 2025-02-18 | Ucl Business Ltd | Engineered regulatory T cell |
| GB201915359D0 (en) | 2019-10-23 | 2019-12-04 | Ucl Business Ltd | Engineered regulatory t cell |
-
2020
- 2020-10-22 AU AU2020370033A patent/AU2020370033A1/en not_active Abandoned
- 2020-10-22 EP EP20800254.3A patent/EP4048294A1/en active Pending
- 2020-10-22 CA CA3154606A patent/CA3154606A1/en active Pending
- 2020-10-22 WO PCT/GB2020/052659 patent/WO2021079122A1/en not_active Ceased
- 2020-10-22 CN CN202080076993.4A patent/CN114641564B/zh not_active Expired - Fee Related
- 2020-10-22 US US17/771,466 patent/US12643932B2/en active Active
- 2020-10-22 JP JP2022523913A patent/JP2022553540A/ja active Pending